Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic thrombolysis with alteplase between 3–4.5 hours in acute ischaemic stroke
2009-012654-20Phase 3Terminated
- Sponsor
- Policlinico Gemelli
- Start
- May 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of tissue-plasminogen activator in ischemic stroke, sponsored by Policlinico Gemelli. Primary endpoint: Favorable functional outcome (mRS 0–2). Started May 2009; status: terminated.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2009-012654-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012654-20.